Updated
Updated · WRAL News · Jun 1
UNC Scientists Warn Medetomidine Spread in North Carolina Drugs Since 2022
Updated
Updated · WRAL News · Jun 1

UNC Scientists Warn Medetomidine Spread in North Carolina Drugs Since 2022

1 articles · Updated · WRAL News · Jun 1
  • Medetomidine has been showing up in North Carolina street-drug samples since 2022, with a Tarboro sample in April containing the sedative in a multi-drug mix, UNC’s Street Drug Analysis Lab said.
  • UNC researchers warned the veterinary sedative—first identified in the illegal drug supply in 2021—can trigger life-threatening withdrawal; stopping suddenly can cause severe hypertension and even a heart attack requiring ICU care.
  • CDC guidance says medetomidine is more potent and longer-acting than clonidine and Xylazine, and overdoses often also involve fentanyl, so naloxone should still be used to restore breathing.
  • Chicago, Philadelphia and Pittsburgh emergency rooms have already been strained by the drug, and UNC scientists say North Carolina has not reached that point but is trying to slow its spread with low-cost test strips and education.
How are criminal labs mass-producing a potent animal drug for the streets?
With withdrawal overwhelming ICUs, are hospitals prepared for this new super-sedative?
Did banning one veterinary sedative inadvertently create a more lethal drug crisis?

Medetomidine Contamination in the U.S. Drug Market: A New Crisis in Overdose Response and Harm Reduction

Overview

Medetomidine, a powerful veterinary sedative, has quickly become a major and alarming contaminant in the U.S. illicit drug supply. Law enforcement agencies have reported a sharp rise in drug seizures containing medetomidine, showing that its spread is now widespread across many regions. This sudden and unpredictable appearance in street drugs poses a serious public health threat, making overdose responses more difficult and increasing risks for people who use drugs. Experts are concerned that the presence of highly toxic chemicals like medetomidine and xylazine could undo recent progress in reducing overdose deaths, highlighting the urgent need for new public health strategies.

...